A study on cognitive dysfunction improvement of aripiprazole for Japanese schizophrenia patients.

Trial Profile

A study on cognitive dysfunction improvement of aripiprazole for Japanese schizophrenia patients.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Aripiprazole (Primary) ; Risperidone
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Oct 2014 Status changed from not yet recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
    • 02 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top